---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-040845"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2026-08-31T20:59:24+00:00"
generated_at: "2026-08-31T21:02:33.878809+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# DNA X regains Nasdaq equity compliance; monitor period through Aug 2027

## Summary
- Received Nasdaq Panel letter on Aug 28, 2026 confirming compliance with Listing Rule 5550(b)(1) ($2.5M stockholders' equity requirement).
- Securities remain subject to delisting if compliance not maintained until Nov 18, 2026.
- Mandatory panel monitor until Aug 28, 2027; new non-compliance triggers delisting determination without cure period.
- Company may request hearing with Panel if delisting is proposed.

## SEC filing metadata
- accession: 0001493152-26-040845
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2026-08-31T20:59:24+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315226040845/0001493152-26-040845-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315226040845/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-040845
- JSON: https://secwatch.observer/filing/0001493152-26-040845.json
- Plain text: https://secwatch.observer/filing/0001493152-26-040845.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.